List of works - Matthew D Hellmann

Adding to the checkpoint blockade armamentarium

scientific article published on 01 February 2019

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

scientific article published on 15 November 2019

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection

article

Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC

scientific article published on 11 February 2020

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

scientific article published on 03 March 2016

Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer

scientific article published on 21 November 2019

Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.

scientific article

Deep learning to estimate RECIST in patients with NSCLC treated with PD-1 blockade

scientific article published on 21 September 2020

Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

scientific article published on 12 December 2018

Entinostat plus pembrolizumab in patients with metastatic NSCLC previously treated with anti-PD-(L)1 therapy

scientific article published on 17 November 2020

Escape from nonsense-mediated decay associates with anti-tumor immunogenicity

scientific article published on 30 July 2020

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

scientific article published on 03 May 2019

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

scientific article published on 4 January 2018

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

scientific article published on 2 November 2017

Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer

scientific article published on 08 July 2021

Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers

scientific article published on 12 May 2020

Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child

scientific article published on 28 June 2021

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

scientific article published on 02 October 2020

Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition

scientific article published on 27 January 2021

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

scientific article published on 16 April 2018

Neoantigen-directed immune escape in lung cancer evolution

scientific article published on 20 March 2019

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer

scientific article published on 28 September 2019

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

scientific article published on 16 April 2018

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

scientific article published on 15 February 2019

Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade

scientific article published on 14 August 2020

Protein-altering germline mutations implicate novel genes related to lung cancer development

scientific article published on 11 May 2020

The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer

scientific article published on 24 July 2020

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer

scientific article published on 21 May 2019

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

scientific article published on 14 January 2019

Use of Circulating Tumor DNA for Cancer Immunotherapy

scientific article published on 08 July 2019

List of works by Matthew D Hellmann